Activiteiten

Activiteiten per jaar 2003 2006 2007 2012 2019 2023 2024 2024

• 8 Talk or presentation at a conference
• 4 Membership of external research organisation
• 3 Participation in conference
• 2 Participation in workshop, seminar
• 5 Meer
  • 2 Membership of peer-review panel or committee
  • 2 Talk or presentation at a workshop/seminar
  • 1 Participating in or organizing an event at an external academic organisation

Activiteiten per jaar

Zoekresultaten

• Targeting DNMT3B in multiple myeloma: a novel epigenetic-based targeting approach that displays potent anti-myeloma activity and enhances sensitivity to standard of care agents

  Catharina Muylaert (Speaker) & Elke De Bruyne (Speaker)

  2 feb 2024

  Activiteit: Talk or presentation at a conference

• AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

  Niels Vandewalle (Presenter), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Yanmeng Wang (Contributor), Timo De Groof (Contributor), Nathan De Beule (Contributor), Tessa kerre (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)

  12 mrt 2024

  Activiteit: Talk or presentation at a conference

• Mapping the immune heterogeneity within the myeloma microenvironment using single-cell transcriptomics

  Emma Verheye (Speaker), Rong Fan (Contributor), Hatice Satilmis (Contributor), Niels Vandewalle (Contributor), Pauline Bardet (Contributor), Emile Clappaert (Contributor), Daliya Kancheva (Contributor), Elke De Bruyne (Contributor), Karin Vanderkerken (Contributor), Kim De Veirman (Contributor) & Damya Laoui (Contributor)

  3 feb 2023

  Activiteit: Talk or presentation at a conference

• AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia

  Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)

  3 feb 2023

  Activiteit: Talk or presentation at a conference

• MCL1 Inhibitors in Multiple Myeloma

  Kim De Veirman (Contributor), Karin Vanderkerken (Speaker), Elke De Bruyne (Contributor) & Eline Menu (Contributor)

  13 nov 2019

  Activiteit: Talk or presentation at a conference

• G9a/GLP targeting blocks myeloma cell growth and survival by suppressing mTOR- and Myc-signaling

  Elke De Bruyne (Speaker)

  13 jun 2019

  Activiteit: Talk or presentation at a conference

• 28th General Annual Meeting of the Belgian Hematological Society

  Elke De Bruyne (Keynote speaker)

  24 jan 2013 → 26 jan 2013

  Activiteit: Talk or presentation at a conference

• Differential expression of Motility related protein-1 during disease progression in multiple myeloma

  Elke De Bruyne (Speaker)

  27 jan 2006

  Activiteit: Talk or presentation at a conference